Hide metadata

dc.date.accessioned2021-03-13T21:34:54Z
dc.date.available2021-03-13T21:34:54Z
dc.date.created2021-02-01T12:22:40Z
dc.date.issued2020
dc.identifier.citationSue Carter, Carter Kenkel, William M. MacLean, Evan L. Wilson, Steven Ray Haakon Perkeybile, Allison M. Yee, Jason R. Ferris, Craig F. Nazarloo, Hossein P. Porges, Stephen W. Davis, John M. Connelly, Jessica J. Kingsbury, Marcy A. . Is oxytocin “nature’s medicine”?. Pharmacological Reviews. 2020, 72(4), 829-861
dc.identifier.urihttp://hdl.handle.net/10852/84010
dc.description.abstractOxytocin is a pleiotropic, peptide hormone with broad implications for general health, adaptation, development, reproduction, and social behavior. Endogenous oxytocin and stimulation of the oxytocin receptor support patterns of growth, resilience, and healing. Oxytocin can function as a stress-coping molecule, an anti-inflammatory, and an antioxidant, with protective effects especially in the face of adversity or trauma. Oxytocin influences the autonomic nervous system and the immune system. These properties of oxytocin may help explain the benefits of positive social experiences and have drawn attention to this molecule as a possible therapeutic in a host of disorders. However, as detailed here, the unique chemical properties of oxytocin, including active disulfide bonds, and its capacity to shift chemical forms and bind to other molecules make this molecule difficult to work with and to measure. The effects of oxytocin also are context-dependent, sexually dimorphic, and altered by experience. In part, this is because many of the actions of oxytocin rely on its capacity to interact with the more ancient peptide molecule, vasopressin, and the vasopressin receptors. In addition, oxytocin receptor(s) are epigenetically tuned by experience, especially in early life. Stimulation of G-protein–coupled receptors triggers subcellular cascades allowing these neuropeptides to have multiple functions. The adaptive properties of oxytocin make this ancient molecule of special importance to human evolution as well as modern medicine and health; these same characteristics also present challenges to the use of oxytocin-like molecules as drugs that are only now being recognized.
dc.languageEN
dc.publisherAmerican Society for Pharmacology and Experimental
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleIs oxytocin “nature’s medicine”?
dc.typeJournal article
dc.creator.authorSue Carter, Carter
dc.creator.authorKenkel, William M.
dc.creator.authorMacLean, Evan L.
dc.creator.authorWilson, Steven Ray Haakon
dc.creator.authorPerkeybile, Allison M.
dc.creator.authorYee, Jason R.
dc.creator.authorFerris, Craig F.
dc.creator.authorNazarloo, Hossein P.
dc.creator.authorPorges, Stephen W.
dc.creator.authorDavis, John M.
dc.creator.authorConnelly, Jessica J.
dc.creator.authorKingsbury, Marcy A.
cristin.unitcode185,15,12,63
cristin.unitnameSeksjon for kjemisk livsvitenskap - biomolekyler, bio-inspirerte materialer og bioanalytisk kjemi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1884965
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Pharmacological Reviews&rft.volume=72&rft.spage=829&rft.date=2020
dc.identifier.jtitlePharmacological Reviews
dc.identifier.volume72
dc.identifier.issue4
dc.identifier.startpage829
dc.identifier.endpage861
dc.identifier.doihttps://doi.org/10.1124/pr.120.019398
dc.identifier.urnURN:NBN:no-86697
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0031-6997
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/84010/1/829.full.pdf
dc.type.versionPublishedVersion
dc.relation.projectNFR/262613


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International